Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets

Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical company developing first-in-class ...